Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Benzonapthyridine Composition and Uses, 4342 [2014-01436]
Download as PDF
<![CDATA[
4342
Federal Register / Vol. 79, No. 17 / Monday, January 27, 2014 / Notices
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive,
Non-Exclusive, or Partially-Exclusive
Licensing of an Invention Concerning
Dynamic Exoskeletal Orthosis
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
Announcement is made of the
availability for licensing of the
invention set forth in U.S. Patent
Application Serial No. 13/773,776,
entitled ‘‘Dynamic Exoskeletal
Orthosis,’’ filed on February 22, 2013.
The United States Government, as
represented by the Secretary of the
Army, has rights to this invention.
ADDRESSES: Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, Frederick, MD 21702–
5012.
FOR FURTHER INFORMATION CONTACT: For
patent issues, Ms. Elizabeth Arwine,
Patent Attorney, (301) 619–7808. For
licensing issues, Dr. Paul Mele, Office of
Research and Technology Applications
(ORTA), (301) 619–6664, both at telefax
(301) 619–5034.
SUPPLEMENTARY INFORMATION: The
invention relates to an ankle foot
orthosis or brace, in particular to a
dynamic exoskeletal orthosis.
SUMMARY:
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014–01437 Filed 1–24–14; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive,
Non-Exclusive, or Partially-Exclusive
Licensing of an Invention Concerning
Benzonapthyridine Composition and
Uses
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
Announcement is made of the
availability for licensing of the
invention set forth in U.S. Patent
Application Serial No. 13/640,832,
entitled ‘‘Benzonapthyridine
Composition and Uses,’’ filed on April
13, 2011. The United States
Government, as represented by the
Secretary of the Army, has rights to this
invention.
ADDRESSES: Commander, U.S. Army
Medical Research and Materiel
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
18:16 Jan 24, 2014
Jkt 232001
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, Frederick, MD 21702–
5012.
FOR FURTHER INFORMATION CONTACT: For
patent issues, Ms. Elizabeth Arwine,
Patent Attorney, (301) 619–7808. For
licensing issues, Dr. Paul Mele, Office of
Research and Technology Applications
(ORTA), (301) 619–6664, both at telefax
(301) 619–5034.
SUPPLEMENTARY INFORMATION: The
invention relates to compositions
comprising benzonapthridine small
molecule immune potentiators (SMIPs)
that are capable of stimulating or
Modulating an immune response in a
subject that has had pre- or postexposure to a pathogen such as
hemorrhagic fever virus.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014–01436 Filed 1–24–14; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
Defense Acquisition Regulations
System
[Docket No. DARS–2013–0045]
Submission for OMB Review;
Comment Request
ACTION:
Notice.
The Defense Acquisition Regulations
System has submitted to OMB for
clearance the following proposal for
collection of information under the
provisions of the Paperwork Reduction
Act (44 U.S.C. chapter 35).
DATES: Consideration will be given to all
comments received by February 26,
2014.
Title, Associated Form, and OMB
Number: Defense Federal Acquisition
Regulation Supplement (DFARS) part
244, Subcontracting Policies and
Procedures; OMB Control Number
0704–0253.
Type of Request: Extension.
Number of Respondents: 90
Responses per Respondent: 1
Annual Responses: 90
Average Burden per Response:
Approximately 16 hours
Annual Burden Hours: 1,440
Needs and Uses: Administrative
contracting officers use this information
in making decisions to grant, withhold,
or withdraw purchasing system
approval at the conclusion of a
purchasing system review. Withdrawal
of purchasing system approval would
necessitate Government consent to
individual subcontracts.
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
Affected Public: Businesses or other
for-profit and not-for profit institutions.
Frequency: On Occasion.
OMB Desk Officer: Ms. Jasmeet
Seehra.
Written comments and
recommendations on the proposed
information collection should be sent to
Ms. Seehra at the Office of Management
and Budget, Desk Officer for DoD, Room
10236, New Executive Office Building,
Washington, DC 20503.
You may also submit comments,
identified by docket number and title,
by the following method:
Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Instructions: All submissions received
must include the agency name, docket
number, and title for the Federal
Register document. The general policy
for comments and other public
submissions from members of the public
is to make these submissions available
for public viewing on the Internet at
https://www.regulations.gov as they are
received without change, including any
personal identifiers or contact
information provided. To confirm
receipt of your comment(s), please
check https://www.regulations.gov
approximately two to three days after
submission to verify posting (except
allow 30 days for posting of comments
submitted by mail).
DoD Clearance Officer: Ms. Patricia
Toppings.
Written requests for copies of the
information collection proposal should
be sent to Ms. Toppings at WHS/ESD/
Information Management Division, 4800
Mark Center Drive, 2nd Floor, East
Tower, Suite 02G09, Alexandria, VA
22350–3100.
Manuel Quinones,
Editor, Defense Acquisition Regulations
System.
[FR Doc. 2014–01554 Filed 1–24–14; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Department of the Army, Corps of
Engineers
Notice of Availability for the Final
Supplemental Environmental Impact
Statement for the Proposed San
Acacia to Bosque del Apache Project,
Socorro County, New Mexico
Department of the Army, U.S.
Army Corps of Engineers, DoD.
ACTION: Notice of availability—Final
SEIS.
AGENCY:
In accordance with the
National Environmental Policy Act of
SUMMARY:
E:\FR\FM\27JAN1.SGM
27JAN1
]]>Agencies
[Federal Register Volume 79, Number 17 (Monday, January 27, 2014)]
[Notices]
[Page 4342]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01436]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive, Non-Exclusive, or
Partially-Exclusive Licensing of an Invention Concerning
Benzonapthyridine Composition and Uses
AGENCY: Department of the Army, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Announcement is made of the availability for licensing of the
invention set forth in U.S. Patent Application Serial No. 13/640,832,
entitled ``Benzonapthyridine Composition and Uses,'' filed on April 13,
2011. The United States Government, as represented by the Secretary of
the Army, has rights to this invention.
ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command,
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick,
Frederick, MD 21702-5012.
FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION: The invention relates to compositions
comprising benzonapthridine small molecule immune potentiators (SMIPs)
that are capable of stimulating or Modulating an immune response in a
subject that has had pre- or post- exposure to a pathogen such as
hemorrhagic fever virus.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-01436 Filed 1-24-14; 8:45 am]
BILLING CODE 3710-08-P
